cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brachytherapy
Recent studies by B. Alqaisieh and co-authors add new data to brachytherapy findings
December 18th, 2007
In this recently published study, investigators in Leeds, the United Kingdom conducted a study "To compare the visibility of different manufacturers I-125, seeds, and to investigate the effect of differences in dosimetry on treatment planning. Oncura Oncoseed, Oncura Echoseed, IBT Intersource, Bebig Isoseed and Nucletron Selectseed were investigated." "The point dose at increasing distances from each seed type was calculated for three different angles; theta = 0 degrees, 45 degrees and 90 degrees (where theta = 0 degrees lies parallel to seed length). 10 patient plans were used to assess the effect of a change in dosimetry on treatment planning and quality of prostate...
Source: cancer weekly (2007-12-18)
|
